A role for the terminal C5-C9 complement pathway in idiopathic pulmonary fibrosis

• Liv I. B. Sikkeland,
• Liv I. B. Sikkeland,
• Thor Ueland,
• Thor Ueland,
• Thor Ueland,
• May B. Lund,
• May B. Lund,
• Michael Thomas Durheim,
• Michael Thomas Durheim,
• Tom Eirik Mollnes,
• Tom Eirik Mollnes,
• Tom Eirik Mollnes,
• Tom Eirik Mollnes

Affiliations

Liv I. B. Sikkeland

Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway

Liv I. B. Sikkeland

Department of Respiratory Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway

Thor Ueland

Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway

Thor Ueland

Institute of Internal Medicine, Oslo University Hospital, University of Oslo, Oslo, Norway

Thor Ueland

K. G. Jebsen, Thrombosis Research Center, University of Tromsø, Tromsø, Norway

May B. Lund

Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway

May B. Lund

Department of Respiratory Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway

Michael Thomas Durheim

Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway

Michael Thomas Durheim

Department of Respiratory Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway

Tom Eirik Mollnes

K. G. Jebsen, Thrombosis Research Center, University of Tromsø, Tromsø, Norway

Tom Eirik Mollnes

Department of Immunology, Oslo University Hospital Rikshospitalet, University of Oslo, Oslo, Norway

Tom Eirik Mollnes

Research Laboratory, Nordland Hospital, Bodø, Norway

Tom Eirik Mollnes

Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway